On September 22, 2026, BlackRock, Inc. disposed of 2.89 million H shares of FOSUN PHARMA (02196) in an off-exchange transaction, with consideration in the form of non-cash assets, as BlackRock ceased to hold a security interest in the shares. The transaction was not a direct secondary-market dealing.
Prior to the disposal, BlackRock's long position in FOSUN PHARMA was 34.78 million shares, representing 6.30%; following the disposal, the holding changed to 31.89 million shares, with the long position ratio falling to 5.78%.